Richard Pratley

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

Vlado Perkovic, Katherine R. Tuttle, Peter Rossing et al. · New England Journal of Medicine · 2024 · 1.2K citations

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease

Peter Rossing, Florian M.M. Baeres, George L. Bakris et al. · Nephrology Dialysis Transplantation · 2023 · 221 citations · Full text

Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

Mikhail Kosiborod, John Deanfield, Richard Pratley et al. · The Lancet · 2024 · 216 citations

Heart Failure, Cardiovascular Disease, Cardiovascular Pharmacology +9

Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

Frederik Persson, Stephen C. Bain, Ofri Mosenzon et al. · Diabetes Care · 2021 · 61 citations · Full text

Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin

Schafer Boeder, Michael J. Davies, Janet B. McGill et al. · Diabetes Technology & Therapeutics · 2024 · 14 citations · Full text